Diagnosis and Management of Idiopathic Persistent Iritis after Cataract Surgery (IPICS).
Diagnosis and Management of Idiopathic Persistent Iritis after Cataract Surgery (IPICS).
复制标题
白内障手术后特发性持续性虹膜炎的诊断和治疗(IPICS)。
DOI:
10.1016/j.ajo.2021.10.004
复制
发表时间:
2022
影响因子:
4.2
通讯作者:
Perez,VictorL
中科院分区:
文献类型:
--
作者:
Soifer,Matias;Mousa,HazemM;Jammal,AlessandroA;Savarain,Christian;Perez,VictorL
PurposeTo investigate the diagnosis and management of patients with idiopathic persistent iritis after cataract surgery (IPICS).DesignRetrospective interventional case series.MethodsPatients diagnosed with IPICS were evaluated for demographic and clinical characteristics and immune blood markers. Those with more than 6 months of follow-up were evaluated for treatment efficacy to achieve remission (ie, absence of inflammation for 3 months), with either exclusive slow tapering of topical steroids or the need for systemic immunosuppression.ResultsForty-five patients presented with IPICS. Most were African American (39, 86.7%) or female (33, 77.3%). Antinuclear antibodies were present in 23 (69.9%) of patients. Main complications were steroid dependency (38,84.4%), glaucoma (24,53.5%), and macular edema (11,37.5%). Thirty two patients presented treatment follow up. On these,the proposed treatment strategy achieved remission in 30 (93.8%) of cases in a mean of 6.1 months via tapering of topical steroids in 15 (46.9%) of patients. However, in 17 (53.1%) of cases, adjuvant anti-inflammatory systemic medication was indicated. Meloxicam use was associated with remission in 11 (64.7%) of these patients and, in a minority with persistent iritis, treatment was escalated to methotrexate, which was successful in 4 (100%) of the cases.ConclusionsIPICS is a distinct clinical anterior uveitis most common in African American and female patients, characterized by an unexpected onset of iritis after cataract surgery and high rates of steroid dependency, glaucoma, and macular edema. It is best treated with an initial slow taper of topical steroids; although adjuvant systemic anti-inflammatory therapy may be necessary to obtain remission and avoid complications.